Sleep Scientists Win Prestigious ‘American Nobel’ for Narcolepsy Breakthrough

Two researchers who spent decades uncovering what truly causes narcolepsy — a discovery that upended long-held assumptions about sleep — have won the 2026 Albert Lasker Basic Medical Research Award, one of the most prestigious honors in medicine.

Emmanuel Mignot, a sleep scientist at Stanford University, and Masashi Yanagisawa, a molecular biologist at the University of Tsukuba in Japan, were recognized for their discovery of the role of orexin, a brain chemical that regulates wakefulness. Their findings linked narcolepsy to the loss of orexin-producing neurons, a breakthrough that shifted the field from vague theories about sleep disorders to a concrete biological cause.

The Lasker Awards, often called the "American Nobels," have a track record of foreshadowing future Nobel Prizes. This year's announcement drew quick attention from sleep researchers and neurologists, with several calling it a long-overdue acknowledgement of work that transformed both basic science and clinical understanding.

The path to the prize was not straightforward. Mignot and Yanagisawa initially worked on different questions — one hunting for a narcolepsy gene, the other studying brain receptors — before their paths converged in the mid-1990s. According to Endpoints News, the connection began almost as a running joke between two scientists who shared a hunch that the same molecule might matter to both of their projects.

Their collaboration helped confirm that narcolepsy, affecting roughly one in every 2,000 to 1 in 2,500 people in the U.S., is tied to an autoimmune attack on orexin neurons. The finding opened avenues for new diagnostic tests and targeted therapies that are still being explored today.

The award was announced on September 10, 2026, by the Lasker Foundation in New York. Neither Mignot nor Yanagisawa has publicly commented on future research plans, but colleagues say the recognition could intensify efforts to turn the orexin discovery into treatments for narcolepsy and other sleep disorders, including insomnia and shift-work fatigue.